CClinicalTrials.gg
CompletedNCT06558617Updated Aug 20, 2024

Evaluating SARC-F, SARC-CalF, and Calf Circumference as Diagnostic Tools for Sarcopenia in Thai Older Adults: Results From a Nationwide Study

An observational study in Sarcopenia and Diagnosis, sponsored by Siriraj Hospital. Completed at 1 site in Thailand. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-20.

Sponsored by Siriraj Hospital · Observational

Study type
Observational
Model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
2,543
Ages
60 Years and older
Sex
All
01

Study summary

As the elderly population grows, musculoskeletal disorders, including sarcopenia, have become a critical area of study due to their association with falls and fractures. Sarcopenia, characterized by decreased muscle mass, is prevalent among older adults and poses a significant risk for falls. This study aimed to assess the effectiveness of the SARC-F and SARC-CalF questionnaires, along with calf circumference measurements, in screening for sarcopenia among Thai community-dwelling older adults, following the Asian Working Group on Sarcopenia (AWGS) 2019 criteria.

Read the detailed description

The data utilized in this analysis were derived from the Thai Musculoskeletal Diseases Nationwide Study. This cross-sectional study targeted Thai adults aged 60 years and older, conducted between March 2021 and August 2022. Participants were sampled using a multi-level sampling technique to ensure representativeness from community-dwelling older adults across 12 provinces, encompassing Thailand's six primary geographical regions.

Participants were evaluated for possible sarcopenia or sarcopenia, according to AWGS 2019 criteria, by using SARC-F questionnaire, calf circumference measurement, SARC-CalF questionnaire, and appendicular skeletal muscle mass (ASM).

02

Conditions studied

  • Sarcopenia
  • Diagnosis

Browse trials for

Keywords

  • sarcopenia
  • calf circumference
  • SARC-F questionnaire
  • diagnostic accuracy
  • elderly
03

In context

Sarcopenia

1,208 studies on the registry are indexed under Sarcopenia; 402 are open to participants now.

This study's enrollment of 2,543 is above the median of 120 across 419 observational studies indexed under Sarcopenia.

Browse Sarcopenia studies →

Lead sponsor

Siriraj Hospital is the lead sponsor of 95 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Community-dwelling older Thai adults living at that area for at least 1 year

Inclusion criteria

  • Thai adults aged 60 years and older

Exclusion criteria

Exclusion Criteria:

  • missing data on SARC-F, SARC-CalF, and calf circumference
  • unable to walk independently
  • bedridden individuals
  • neuromuscular disorders or severe comorbidities that could impair their ability to perform performance-based tests
05

Study design

Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrollment
2,543 participants (actual)
Patient registry
No

Groups and cohorts

  • Thai community-dwelling older adults

    Diagnostic Test: SARC-F Questionnaire · Diagnostic Test: Calf Circumference Measurement · Diagnostic Test: SARC-CalF Questionnaire

Interventions

  • Diagnostic testSARC-F Questionnaire

    The SARC-F scale consists of five components: strength, walking assistance, rising from a chair, stair climbing, and falls. These elements were selected to reflect changes in health status related to the effects of sarcopenia. Scores on the SARC-F scale range from 0 to 10, composed of five domains, assesses strength, walking assistance, raising from a chair, stair climbing and falls. Each domain score ranges from 0-2. A SARC-F score of ≥4 was considered abnormal. The Thai-version SARC-F questionnaire has been validated in Thai older adults.

  • Diagnostic testCalf Circumference Measurement

    Calf circumference was measured using a nonelastic tape measure while the participant was standing with relaxed legs. The tape was placed snugly and flat around the widest part of the calf, parallel to the floor. According to the AWGS 2019 criteria, calf circumferences were considered abnormal if they were less than 34 cm for males and less than 33 cm for females.

  • Diagnostic testSARC-CalF Questionnaire

    This questionnaire integrates the SARC-F and calf circumference as a trigger for case finding. If the calf circumference is below the cut-off value, 10 points are added to the SARC-F score for evaluation. The SARC-CalF score ranges from 0 to 20, with a score of ≥11 considered abnormal for sarcopenia screening.

06

What researchers measure

Primary outcomes

  1. Appendicular skeletal muscle mass (ASM)

    To assess appendicular skeletal muscle mass (ASM), we used the Tanita RD-545, a dual-frequency bioelectrical impedance analysis (BIA) device (Tanita Corporation, Tokyo, Japan). Previous studies have demonstrated that this BIA method is reliable and comparable to dual-energy X-ray absorptiometry (DXA) for diagnosing sarcopenia in Thai elderly adults. The appendicular skeletal muscle mass index (ASMI) was calculated by dividing the ASM by the square of the height. According to the 2019 criteria of the AWGS, low muscle mass is defined as \<7.0 kg/m² for men and \<5.7 kg/m² for women.

    Time frame: up to 4 weeks

  2. Handgrip strength

    Participants were asked to squeeze a digital Smedley spring hand dynamometer (Takei 5401 Digital Dynamometer; Takei, Tokyo, Japan) with maximum effort while standing with fully extended arms at their sides. The grip size was adjusted for each participant's hand size, and 2 or 3 trials were performed, with the highest output value recorded. Handgrip strengths \< 28 kg in males and \< 18 kg in females were classified as low muscle strength, per the AWGS 2019 criteria.

    Time frame: up to 4 weeks

  3. 5-time sit-to-stand test (5TSTS)

    Participants were directed to sit upright on armless chairs with their backs supported firmly by the backrest. They were then instructed to stand up as quickly as possible for 5 repetitions with their arms crossed, trunk upright, and hips and knees fully extended. The time taken by each participant to complete the test from the initial sitting to the fifth sitting was recorded. The test is considered abnormal if it takes equal or more than 12 seconds to complete the task.

    Time frame: up to 4 weeks

07

Study locations

1 site
  • Faculty of Medicine Siriraj Hospital, Mahidol University
    Bangkoknoi, Bangkok 10700, Thailand
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06558617
Lead sponsor
Siriraj Hospital
Collaborators
National Research Council of Thailand
Responsible party
Panai Laohaprasitiporn, MD (Assistant Professor, Siriraj Hospital) — Principal investigator
First posted
Aug 16, 2024
Start date
Mar 1, 2021
Primary completion
Aug 31, 2022
Completion
Aug 31, 2022
Last update
Aug 20, 2024

Study contacts

Apichat Asavamongkolkul, MD
principal investigator · Siriraj Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion